格隆汇2月13日丨爱康医疗(01789.HK)发布公告，2026年2月13日耗资676.1万港元回购108.8万股，回购 价格每股6.15-6.24港元。 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 愛康醫療控股有限公司 (於開曼群島註冊成立的有限責任公司) 呈交日期： 2026年2月13日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 01789 | 說明 | 愛康醫療 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | | | | 事件 | 已 ...

Group 1 - The core viewpoint of the article is that Aikang Medical (01789.HK) has seen a significant increase in its stock price, rising over 5% [1] - As of the time of reporting, the stock price reached 6.17 HKD, reflecting a gain of 5.29% [1] - The trading volume for Aikang Medical was reported at 20.71 million HKD [1]

Core Viewpoint - Aikang Medical (01789) shares rose over 5%, currently up 5.29% at HKD 6.17, with a trading volume of HKD 20.71 million [1] Group 1: Company Developments - Aikang Medical announced on February 9 that it has secured six bids from December 2024 to January 2026, involving its self-developed K3 robot system, K3+ robot system, Visual Treatment Solution, and a digital orthopedic full-process solution [1] - The total bid value for four of the projects amounts to RMB 23.54 million, while the remaining two bids have not yet disclosed their values [1] - Among the six projects, one bid for Shandong Provincial Hospital is valued at RMB 4.46 million, expected to recognize revenue in 2026, with two bids awarded this year from Zhejiang University School of Medicine First Affiliated Hospital and a hospital in Shandong [1]

Core Viewpoint - Aikang Medical (01789) has seen a stock price increase of over 5%, currently trading at 6.17 HKD with a transaction volume of 20.71 million HKD, following the announcement of six successful bids for various medical systems and solutions [1] Group 1: Company Developments - Aikang Medical announced on February 9 that it has secured six bids from December 2024 to January 2026, which include its self-developed K3 robot system, K3+ robot system, Visual Treatment Solution, and a comprehensive digital orthopedic solution [1] - The total bid amount for four of these projects is 23.54 million RMB, while the amounts for the remaining two bids have yet to be disclosed [1] - One of the notable projects includes a bid for Shandong Provincial Hospital, valued at 4.46 million RMB, expected to recognize revenue in 2026 [1] Group 2: Market Response - Following the announcement, Aikang Medical's stock price rose by 5.29%, indicating positive market sentiment towards the company's recent achievements [1] - The trading volume reached 20.71 million HKD, reflecting increased investor interest in the company's future prospects [1]

Core Viewpoint - Aikang Medical (01789) announced that its wholly-owned subsidiary, Beijing Yidian Lingdong Technology Co., Ltd., has successfully won the bid for the orthopedic hip joint surgery navigation system and other equipment projects at the First Affiliated Hospital of Zhejiang University School of Medicine [1] Group 1 - Aikang Medical's subsidiary has secured a significant contract in the medical equipment sector [1] - The project involves advanced technology for orthopedic surgeries, indicating a focus on innovation in healthcare [1]

Core Viewpoint - Aikang Medical (01789) announced that its wholly-owned subsidiary, Beijing Yidian Lingdong Technology Co., Ltd., has successfully won the bid for the orthopedic hip joint surgery navigation system and other equipment projects at the First Affiliated Hospital of Zhejiang University School of Medicine [1] Company Summary - Aikang Medical's subsidiary has secured a significant contract, indicating the company's growth and expansion in the medical technology sector [1]

Group 1 - The company, Aikang Medical, announced that its wholly-owned subsidiary, Beijing Yidian Lingdong Technology Co., Ltd., successfully won the bid for the orthopedic hip joint surgery navigation system project at Zhejiang University School of Medicine First Affiliated Hospital [1] - The K3 intelligent surgical robot system, developed entirely in-house, is designed to be compact and efficient, providing functionalities from preoperative planning to intraoperative assistance, aiming to enhance surgical precision and efficiency [1] - The K3+ robot system received approval from the National Medical Products Administration on January 15, 2026, making it the first all-joint surgical robot in China capable of performing revision surgeries, covering hip, knee, and unicompartmental indications [1] Group 2 - The Visual Treatment Solution (VTS system) integrates medical-engineering interaction for preoperative planning and real-time monitoring, aimed at improving the surgical performance and clinical efficacy of total hip arthroplasty [1] - The company is actively promoting digital orthopedic construction, utilizing smart technology to enhance the diagnostic and treatment levels of medical institutions [2] - The digital orthopedic solutions offered by the company encompass a full range of services, including 3D modeling, surgical planning, 3D model printing, customized surgical tools, and customized prosthetics [2]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容而產生或因倚 賴該等內容而引致的任何損失承擔任何責任。 （於開曼群島註冊成立的有限責任公司） (股份代號：1789) 自願性公告 業務更新 本公告由愛康醫療控股有限公司（「本公司」，連同其附屬公司稱為「本集團」）自願 作出，以向本公司股東（「股東」）及潛在投資者提供有關本集團最新業務發展的最 新資料。 本公司董事（「董事」）會（「董事會」）欣然宣佈，本公司全資附屬公司北京壹點靈 動科技有限公司近日成功中標浙江大學醫學院附屬第一醫院骨科髖關節手術導 航系統等設備項目。此外，於2024年12月至2026年1月期間，本集團獲得多項中 標，中標概要載列如下： | | 中標結果╱ | | | --- | --- | --- | | 招標者 | 簽約日期 | 中標公告價格 （人民幣元） | | • 山東省立醫院 | 2024年12月 | （附註） 446萬 | | • 青島市中醫醫院（市海慈醫院） | 2025年08月 | 680 萬 | | • 北京大學第三醫院 | ...

Group 1 - The company, Aikang Medical (01789), announced a share buyback on February 6, 2026, spending HKD 3.7904 million to repurchase 640,000 shares [1] - The buyback price per share ranged from HKD 5.88 to HKD 5.93 [1]